Rev 10/11/2026 · Master Clinical Training Suite

DLP 29: Diana Prince

Complete Clinical Lifecycle: Patient Portal Registration, Incomplete Baseline Aesthetic Skin & Modality Intake Screening (AES-INJECTABLE-INTAKE-BASELINE), Arrival Clock Reset, Check-In Safety Clearance, Visible Rooming, Clinical Intake Vitals, Botox Cosmetic Anatomical Neurotoxin Therapy, and Square Terminal POS Checkout.

Scenario 29 AES-INJECTABLE-INTAKE-BASELINE Dr. Ravi Sundaram, MD Square Terminal POS ($800.00) 100% Pass Validated
Interactive Scene Jump Points
Click any chapter to seek directly to that clinical milestone

Clinical Safety Governance

Scenario Code: DLP-SCR-29

Governing Rule: AES-INJECTABLE-INTAKE-BASELINE (Dermal filler planned without vascular disclosure)

Clinical Protocol: When a patient requests dermal filler contouring during portal intake, the engine triggers an automatic front-desk safety alert requiring documented vascular risk disclosure, aspiration protocol affirmation, and on-site hyaluronidase reversal kit verification.

Patient & Provider Demographics

Patient Persona: Diana Prince (Female, DOB: 1990-05-15, Age 36)

Address: 1200 E 15th St, Edmond, OK 73013

Phone: (405) 555-0129 | SSN Last 4: 4029

Attending Clinician: Dr. Ravi Sundaram, MD

Clinical Coordinator: Sarah Jenkins | Clinical Assistant: Alex Morgan, PA-C

Documented Treatment & Settlement

Primary Treatment: Restylane L 1.0mL with Micro-Cannula Technique (1 syringe, $800.00)

Adjunctive Service: Comprehensive Aesthetic Consultation & Evaluation ($0.00)

Tender Method: Square Terminal POS Device (In-Person)

Transaction Settlement: Approved #TX-73013-POS | Balance Due: $0.00

Audit Invariant: Patient card retained in Lane 12 (Completed) for statutory census reconciliation.